factual

Fourth dose authorization based on antibody levels not outcomes

The fourth dose authorization (over age 50 in the US) was granted largely on the basis that it raises antibody levels back toward prior levels, not on proof that a healthy 51-year-old gets a further reduction in severe disease or hospitalization.

factualpending

Speaker

Vinay Prasad

Evidence Quote

“no one in my mind has proven that person has a further reduction in severe disease or hospitalization by getting the fourth dose.”

Source

Vinay Prasad on the Pandemic— EconTalk
Created: 6/13/2026, 12:17:03 AM

Your notes

Loading notes...